Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

NCT07110415 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

2708

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Heart Disease
Cardiac Dysfunction

Interventions

DRUG: Yangxinshi tablet
DRUG: Blank control

Sponsor

SPH Qingdao Growful Pharmacetical Co.,Ltd